Home
ATHA
ATHA News

Latest Athira Pharma Inc. (ATHA) News on October 23, 2025

This Athira Pharma Insider Increased Their Holding By 111% Last Year

Simply Wall St.

5 months ago

This Athira Pharma Insider Increased Their Holding By 111% Last Year

Athira Pharma to present data from first-in-human Phase 1 trial of ATH-1105

TipRanks

5 months ago

Athira Pharma to present data from first-in-human Phase 1 trial of ATH-1105

Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit

GlobeNewswire

5 months ago

Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit

Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates

GlobeNewswire

5 months ago

Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates

Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates

GlobeNewswire

8 months ago

Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates

MT Newswires

8 months ago

Terns Pharmaceuticals Names Andrew Gengos as Chief Financial Officer

Can Athira Pharma (NASDAQ:ATHA) Afford To Invest In Growth?

Simply Wall St.

9 months ago

Can Athira Pharma (NASDAQ:ATHA) Afford To Invest In Growth?

Athira Pharma Insider Ups Holding By 111% During Year

Simply Wall St.

10 months ago

Athira Pharma Insider Ups Holding By 111% During Year

Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND

GlobeNewswire

a year ago

Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND

Athira exploring strategic alternatives after Alzheimer’s failure

BioPharma Dive

a year ago

Athira exploring strategic alternatives after Alzheimer’s failure

Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates

GlobeNewswire

a year ago

Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates

US Penny Stocks: November 2024's Top Picks To Consider

Simply Wall St.

a year ago

US Penny Stocks: November 2024's Top Picks To Consider

Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Meeting

GlobeNewswire

a year ago

Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Meeting

Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases

GlobeNewswire

a year ago

Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases

Biotech Stock Roundup: NVAX Vaccine Approval, ALNY, ATHA Stock Dive on Updates & More

Zacks

a year ago

Biotech Stock Roundup: NVAX Vaccine Approval, ALNY, ATHA Stock Dive on Updates & More

MT Newswires

a year ago

Top Midday Decliners

MT Newswires

a year ago

Sector Update: Health Care Stocks Retreat Wednesday Afternoon

Alzheimer’s Trial Failure Sends Athira Stock Down 75%

Barrons.com

a year ago

Alzheimer’s Trial Failure Sends Athira Stock Down 75%

Athira’s stock topples after Alzheimer’s drug flops in Phase II/III trial

Pharmaceutical Technology

a year ago

Athira’s stock topples after Alzheimer’s drug flops in Phase II/III trial

ATHA Stock Tanks as Alzheimer's Study Fails to Meet Primary Goal

Zacks

a year ago

ATHA Stock Tanks as Alzheimer's Study Fails to Meet Primary Goal

MT Newswires

a year ago

Sector Update: Health Care Stocks Fall Premarket Wednesday

MT Newswires

a year ago

Sector Update: Health Care

Athira Pharma's Alzheimer's Candidate Fails To Improve Cognition And Function In Patients With Mild/Moderate Disease, Stock Sinks

Benzinga

a year ago

Athira Pharma's Alzheimer's Candidate Fails To Improve Cognition And Function In Patients With Mild/Moderate Disease, Stock Sinks

MT Newswires

a year ago

Athira Pharma Alzheimer's Treatment Candidate Fails to Meet Targets -- Shares Sink After Hours

Athira Pharma Announces Topline Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton for Mild-to-Moderate Alzheimer’s Disease

GlobeNewswire

a year ago

Athira Pharma Announces Topline Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton for Mild-to-Moderate Alzheimer’s Disease

Are Medical Stocks Lagging Athira Pharma (ATHA) This Year?

Zacks

a year ago

Are Medical Stocks Lagging Athira Pharma (ATHA) This Year?

Is Athira Pharma (ATHA) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is Athira Pharma (ATHA) Stock Outpacing Its Medical Peers This Year?

Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates

GlobeNewswire

a year ago

Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates

Athira Pharma Presents Preclinical Data Demonstrating New Insights into the Mechanism by Which Fosgonimeton Protects Neurons from Alzheimer’s Disease-Related Pathology at the Alzheimer’s Association International Conference (AAIC) 2024

GlobeNewswire

a year ago

Athira Pharma Presents Preclinical Data Demonstrating New Insights into the Mechanism by Which Fosgonimeton Protects Neurons from Alzheimer’s Disease-Related Pathology at the Alzheimer’s Association International Conference (AAIC) 2024

Athira (ATHA) Completes Dosing in Alzheimer's Study, Stock Up

Zacks

a year ago

Athira (ATHA) Completes Dosing in Alzheimer's Study, Stock Up

MT Newswires

a year ago

Athira Pharma Doses Last Patient Alzheimer's Treatment Study

Athira Pharma Announces Last Patient Completed LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease

GlobeNewswire

a year ago

Athira Pharma Announces Last Patient Completed LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease

retail investors who own 35% along with institutions invested in Athira Pharma, Inc. (NASDAQ:ATHA) saw increase in their holdings value last week

Simply Wall St.

a year ago

retail investors who own 35% along with institutions invested in Athira Pharma, Inc. (NASDAQ:ATHA) saw increase in their holdings value last week

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 06/26/2024

Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer’s Disease Patients

GlobeNewswire

a year ago

Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer’s Disease Patients

Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)

GlobeNewswire

a year ago

Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

We're A Little Worried About Athira Pharma's (NASDAQ:ATHA) Cash Burn Rate

Simply Wall St.

a year ago

We're A Little Worried About Athira Pharma's (NASDAQ:ATHA) Cash Burn Rate

Athira Pharma to Participate in Upcoming June Conferences

GlobeNewswire

a year ago

Athira Pharma to Participate in Upcoming June Conferences

Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action

GlobeNewswire

a year ago

Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action

Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates

GlobeNewswire

a year ago

Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates

Sidoti Events, LLC's Virtual May Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual May Micro-Cap Conference

Athira Pharma to Participate in Upcoming May Conferences

GlobeNewswire

a year ago

Athira Pharma to Participate in Upcoming May Conferences

One Athira Pharma Insider Raised Their Stake In The Previous Year

Simply Wall St.

2 years ago

One Athira Pharma Insider Raised Their Stake In The Previous Year

Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer

GlobeNewswire

2 years ago

Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer

Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease

GlobeNewswire

2 years ago

Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease

Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting

GlobeNewswire

2 years ago

Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting

Is Stryker (SYK) Stock Outpacing Its Medical Peers This Year?

Zacks

2 years ago

Is Stryker (SYK) Stock Outpacing Its Medical Peers This Year?

Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference

GlobeNewswire

2 years ago

Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference

Is Arcutis Biotherapeutics (ARQT) Outperforming Other Medical Stocks This Year?

Zacks

2 years ago

Is Arcutis Biotherapeutics (ARQT) Outperforming Other Medical Stocks This Year?

Athira Pharma, Inc. (ATHA) is a Great Momentum Stock: Should You Buy?

Zacks

2 years ago

Athira Pharma, Inc. (ATHA) is a Great Momentum Stock: Should You Buy?

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates

GlobeNewswire

2 years ago

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates

2 “Strong Buy” Penny Stocks That Could Rally All the Way to $10 (or More)

TipRanks

2 years ago

2 “Strong Buy” Penny Stocks That Could Rally All the Way to $10 (or More)

Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)

GlobeNewswire

2 years ago

Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)

Princeton Bancorp Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

2 years ago

Princeton Bancorp Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

PCB Bancorp (PCB) Reports Decline in Q4 Earnings and Annual Net Income for 2023

GuruFocus.com

2 years ago

PCB Bancorp (PCB) Reports Decline in Q4 Earnings and Annual Net Income for 2023

Oportun Financial Corporation (NASDAQ:OPRT) is favoured by institutional owners who hold 53% of the company

Simply Wall St.

2 years ago

Oportun Financial Corporation (NASDAQ:OPRT) is favoured by institutional owners who hold 53% of the company

With 36% ownership, Athira Pharma, Inc. (NASDAQ:ATHA) has piqued the interest of institutional investors

Simply Wall St.

2 years ago

With 36% ownership, Athira Pharma, Inc. (NASDAQ:ATHA) has piqued the interest of institutional investors

Dividend Challengers List Ranked By Yield: Top 30

Insider Monkey

2 years ago

Dividend Challengers List Ranked By Yield: Top 30

The RealReal, Inc. (NASDAQ:REAL) has caught the attention of institutional investors who hold a sizeable 45% stake

Simply Wall St.

2 years ago

The RealReal, Inc. (NASDAQ:REAL) has caught the attention of institutional investors who hold a sizeable 45% stake

Business Wire

2 years ago

Evans Bancorp Announces Fourth Quarter and Full Year 2023 Conference Call and Webcast

Cue Biopharma (NASDAQ:CUE) investors are sitting on a loss of 80% if they invested three years ago

Simply Wall St.

2 years ago

Cue Biopharma (NASDAQ:CUE) investors are sitting on a loss of 80% if they invested three years ago

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01

GlobeNewswire

2 years ago

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01

Solid Biosciences (SLDB) Rises 271% in 3 Months: Here's Why

Zacks

2 years ago

Solid Biosciences (SLDB) Rises 271% in 3 Months: Here's Why

Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2023 Update

GlobeNewswire

2 years ago

Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2023 Update

City Office REIT Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

PR Newswire

2 years ago

City Office REIT Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update

GlobeNewswire

2 years ago

Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update

Why WW International Stock Was Sinking Fast This Week

Motley Fool

2 years ago

Why WW International Stock Was Sinking Fast This Week

Alimera Completes Recruitment for the Synchronicity Study

GlobeNewswire

2 years ago

Alimera Completes Recruitment for the Synchronicity Study

Qurate Retail, Inc. to Present at the ICR Conference 2024

Business Wire

2 years ago

Qurate Retail, Inc. to Present at the ICR Conference 2024

Gevo Announces Appointment of Katie Ellet to Board of Directors

GlobeNewswire

2 years ago

Gevo Announces Appointment of Katie Ellet to Board of Directors

Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease

GlobeNewswire

2 years ago

Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease

With 63% ownership, Sterling Bancorp, Inc. (Southfield, MI) (NASDAQ:SBT) insiders have a lot riding on the company's future

Simply Wall St.

2 years ago

With 63% ownership, Sterling Bancorp, Inc. (Southfield, MI) (NASDAQ:SBT) insiders have a lot riding on the company's future

Is Athira Pharma (NASDAQ:ATHA) In A Good Position To Deliver On Growth Plans?

Simply Wall St.

2 years ago

Is Athira Pharma (NASDAQ:ATHA) In A Good Position To Deliver On Growth Plans?

Heritage Announces Launch of Primary Offering of Shares of Common Stock

PR Newswire

2 years ago

Heritage Announces Launch of Primary Offering of Shares of Common Stock

Here's Why One Should Avoid Air Transport (ATSG) Stock Now

Zacks

2 years ago

Here's Why One Should Avoid Air Transport (ATSG) Stock Now

LifeMD and Medifast Partner to Offer Transformative Weight Management Solution

GlobeNewswire

2 years ago

LifeMD and Medifast Partner to Offer Transformative Weight Management Solution

Insider Sell Alert: Director Mary Kelley Sells 33,500 Shares of Vera Bradley Inc (VRA)

GuruFocus.com

2 years ago

Insider Sell Alert: Director Mary Kelley Sells 33,500 Shares of Vera Bradley Inc (VRA)

Bears are Losing Control Over Lifeway (LWAY), Here's Why It's a 'Buy' Now

Zacks

2 years ago

Bears are Losing Control Over Lifeway (LWAY), Here's Why It's a 'Buy' Now

Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies

GlobeNewswire

2 years ago

Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies

Here's Why Sera Prognostics, Inc. (SERA) is a Great Momentum Stock to Buy

Zacks

2 years ago

Here's Why Sera Prognostics, Inc. (SERA) is a Great Momentum Stock to Buy

Scilex Holding Company announces that ZTlido® (lidocaine topical system) will be added as a preferred agent to the Medicaid Preferred Drug List (PDL) in two new states: one Midwestern and one Southern State

GlobeNewswire

2 years ago

Scilex Holding Company announces that ZTlido® (lidocaine topical system) will be added as a preferred agent to the Medicaid Preferred Drug List (PDL) in two new states: one Midwestern and one Southern State

Arthur J. Gallagher & Co. Completes Acquisition of The Evans Agency, LLC

PR Newswire

2 years ago

Arthur J. Gallagher & Co. Completes Acquisition of The Evans Agency, LLC

Companies Like XBiotech (NASDAQ:XBIT) Are In A Position To Invest In Growth

Simply Wall St.

2 years ago

Companies Like XBiotech (NASDAQ:XBIT) Are In A Position To Invest In Growth

Sidoti Events, LLC's Virtual December Small-Cap Conference

ACCESSWIRE

2 years ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

Pennant Acquires Yuma Arizona Hospice Provider

GlobeNewswire

2 years ago

Pennant Acquires Yuma Arizona Hospice Provider

Nukkleus, Inc. Finalizes Transformative Merger with Brilliant Acquisition Corp, Unveiling New Horizons in Digital Asset Solutions for Customers

PR Newswire

2 years ago

Nukkleus, Inc. Finalizes Transformative Merger with Brilliant Acquisition Corp, Unveiling New Horizons in Digital Asset Solutions for Customers

Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors

Business Wire

2 years ago

Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors

Athira Pharma to Participate in Sidoti December Small Cap Investor Conference

GlobeNewswire

2 years ago

Athira Pharma to Participate in Sidoti December Small Cap Investor Conference

GlobeNewswire

2 years ago

CROWN PROPTECH ACQUISITIONS ANNOUNCES RECEIPT OF NOTICE OF LATE FILING FROM NYSE

Grindrod Shipping Holdings Ltd. Announces Unaudited Financial Results for the Three Months and Nine Months Ended September 30, 2023

GlobeNewswire

2 years ago

Grindrod Shipping Holdings Ltd. Announces Unaudited Financial Results for the Three Months and Nine Months Ended September 30, 2023

Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND

GlobeNewswire

2 years ago

Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND

ParkOhio Announces Ratings Upgrade from Moody’s

Business Wire

2 years ago

ParkOhio Announces Ratings Upgrade from Moody’s

Share on Social Networks: